These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6827772)

  • 1. The limitations of anti-arrhythmic drug therapy.
    Shimomura K; Ohe T
    Jpn Circ J; 1983 Jan; 47(1):153-7. PubMed ID: 6827772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS; Oversohl K; Seidl KF
    Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

  • 4. [Unfavorable course of the ventricular preexcitation syndrome. Apropos of 3 cases].
    Poveda Sierra J; Pajarón A; Medrano GA
    Arch Inst Cardiol Mex; 1973; 43(6):837-47. PubMed ID: 4773501
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.
    Rosenbaum MB; Chiale PA; Ryba D; Elizari MV
    Am J Cardiol; 1974 Aug; 34(2):215-23. PubMed ID: 4843156
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M; Noll B; Krappe J
    Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of antiarrhythmic drug efficacy in the treatment of supraventricular arrhythmias.
    Naccarelli GV; Dougherty AH; Berns E; Rinkenberger RL
    Am J Cardiol; 1986 Aug; 58(5):31C-36C. PubMed ID: 3529906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in the treatment and prevention of cardiac arrhythmias.
    Gianelly R; Griffin JR; Harrison DC
    Ann Intern Med; 1967 Apr; 66(4):667-76. PubMed ID: 6023533
    [No Abstract]   [Full Text] [Related]  

  • 10. Aprindine (AC 1802), a new anti-arrhythmic drug.
    Kesteloot H; Van Mieghem W; De Geest H
    Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909
    [No Abstract]   [Full Text] [Related]  

  • 11. The antiarrhythmic effects of propranolol.
    Harrison DC; Griffin JR
    Ann N Y Acad Sci; 1967 Feb; 139(3):997-1002. PubMed ID: 5232352
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies of Norpace (Part X).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):148. PubMed ID: 46728
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical use of oral flecainide.
    Slama R; LeClercq JF
    Drugs; 1985; 29 Suppl 4():28-9. PubMed ID: 4006778
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias.
    Singh BN
    N Z Med J; 1973 Dec; 78(504):482-6. PubMed ID: 4130662
    [No Abstract]   [Full Text] [Related]  

  • 15. [On ajmaline treatment of heart rhythm disorders].
    Forster G; Holzmann M
    Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability].
    Bossi M; Botti G; Campus S; Cardini A; Cherchi A; Coljca A; Di Benedetto A; Folli G; Franzosi P; Geraci E; Lampertico M; Lotto A; Magnani B; Modica G; Selvini A; Serio G; Visioli O
    Minerva Med; 1970 Jan; 61(5):113-20. PubMed ID: 4189651
    [No Abstract]   [Full Text] [Related]  

  • 17. [3-Year experience in the treatment with several arrhythmias with ritmos (ajmalin)].
    Apostolov L; Batalov Z; Mironov P; Panitsa D
    Kardiologiia; 1968 Nov; 8(11):82-9. PubMed ID: 4184833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical contribution in the treatment of paroxysmal tachycardia].
    Tassone F
    Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiarrhythmic drug therapy and prevention of cardiac emergencies in the prehospital phase].
    von Knorre GH
    Z Arztl Fortbild (Jena); 1984; 78(15):621-2. PubMed ID: 6495771
    [No Abstract]   [Full Text] [Related]  

  • 20. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Antiarrhythmic drug therapy.
    Chung EK
    JAMA; 1977 Jan; 237(4):376-9. PubMed ID: 576173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.